STOAF

STOAF

STOAF — originally short for Stockholms Affärsänglar — launched in mid-2008 as a hybrid venture group powered by certified business angels. The financial crisis constrained the first fund's capitalization, though Stoaf I still generated reasonable yields relative to its microfund cohort. General Partners Magnus Eriksson, Klaus Gottwald, Claes Post and CEO Per Anders Wärn built the firm's methodology by researching Silicon Valley best practices and formally publishing their findings in two books authored by co-founder Lennart Ohlsson. The team's senior advisors include former Gartner EVP Peter Sondergaard and Industrifonden's Anna Ljungdahl, embedding institutional-grade governance alongside the angel network. Stoaf III SciTech invests across life sciences, advanced industrial technologies, advanced ICT, and sustainable energy — always B2B and always with strong underlying technology. Portfolio companies confirmed on the firm's site include Swegan (GaN-on-SiC power semiconductors), Limina (cloud-native investment management software), Embedl (AI-driven hardware optimization), Aligned Bio (nanowire biosensors), and Developeration (hemorrhoid surgery devices). The firm structures all its funds to offer limited partners co-investment rights, letting LPs overweight specific sectors or stages inside a professionally selected early-stage portfolio. The geographic footprint concentrates on the Nordic region, with some portfolio firms targeting global industrial and institutional buyer markets. STOAF operates a dedicated internal methodology — called "Catch Early & Ride Longer" — designed to improve start-up prediction accuracy and to structure investment conditions around value inflection points. After financing, the GPs and their certified business angels apply proprietary venture management and exit optimization protocols, refined through internal seminars. The firm maintains no disclosed AUM, but its three-fund track record and a 14-company active portfolio signal a tightly managed, capacity-constrained micro-fund strategy. In its public materials, STOAF highlights that three years into Stoaf III SciTech's five-year investment period the fund had already completed its first 14 investments, indicating a cadence of roughly four to five new deals per year. STOAF's structural distinction lies in its blend of academic research commercialization, business-angel certification, and institutional co-investment architecture. The firm publishes its deal-selection and venture-management methods openly — a posture nearly unheard of in private venture — while simultaneously operating a trained corps of certified angels who serve as both deal-flow scouts and post-investment competence providers. The result is a funding model that behaves more like an industrial R&D commercialization pipeline than a traditional venture capital firm, sourcing innovation from Nordic universities and research institutes and applying a repeatable, documented playbook to shepherd it toward exit.